Page last updated: 2024-08-17

adenosine monophosphate and Infections, Coronavirus

adenosine monophosphate has been researched along with Infections, Coronavirus in 263 studies

Research

Studies (263)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (0.76)24.3611
2020's261 (99.24)2.80

Authors

AuthorsStudies
Avbelj, M; Banjanac, M; Durán-Alonso, MB; Horvat, M; Iskra, J; Petković, H1
Bullen, CK; D'Alessio, FR; Davis, SL; Jain, SK; Jones-Brando, L; Kim, J; Komm, O; Merino, VF; Ordonez, AA; Powell, JD; Thompson, EA; Turner, ML; Villabona-Rueda, AF; Yan, Y; Yolken, RH1
Babusis, D; Bannister, R; Baric, RS; Barrett, KT; Bilello, JP; Bleier, BJ; Brown, AJ; Chun, K; Cihlar, T; Conrad, WS; Dong, S; Du Pont, V; Feng, JY; Gully, KL; Kalla, R; Mackman, RL; Martinez, DR; May, SR; Meganck, RM; Montgomery, SA; Moreira, FR; Murakami, E; Schäfer, A; Sheahan, TP; Subramanian, R; Tang, J; Won, JJ; Zweigart, MR1
Ferrara, F; Trama, U; Vitiello, A; Zovi, A1
Barczi, E; Dinya, E; Fazekas, L; Gajdacsi, J; Hidvegi, E; Maurovich-Horvat, P; Merkely, B; Müller, V; Polivka, L; Sebok, S; Sutto, Z; Szabo, AJ1
Addo, MM; Aepfelbacher, M; Fischer, N; Grundhoff, A; Günther, T; Heyer, A; Jarczak, D; Kluge, S; Lütgehetmann, M; Robitaille, A; Schulze Zur Wiesch, J1
Babusis, D; Baric, RS; Bauer, L; Brown, AJ; Cihlar, T; Clarke, MO; Denison, MR; Feng, JY; Hogg, A; Jordan, R; Leist, SR; Montgomery, SA; Porter, D; Schäfer, A; Sellers, S; Sheahan, TP; Sims, AC; Spahn, JE; Won, J1
Lu, H1
Cao, R; Hu, Z; Liu, J; Shi, Z; Wang, M; Xiao, G; Xu, M; Yang, X; Zhang, L; Zhong, W1
Cihlar, T; Cronin, J; de Wit, E; Feldmann, F; Feldmann, H; Jordan, R; Okumura, A; Scott, D; Thomas, T1
Maxmen, A1
Lu, X; Pan, B; Sun, P; Sun, W; Xu, C1
Li, J; Qi, C; Shen, L; Wang, Y; Zhang, Q1
Elfiky, AA1
De Clercq, E; Li, G1
Anderson, PO1
Brouqui, P; Colson, P; Lagier, JC; Raoult, D; Rolain, JM1
Chen, PL; Hsueh, PR; Huang, CT; Ko, WC; Lee, NY; Lee, PI; Rolain, JM1
Dong, L; Gao, J; Hu, S1
Martinez, MA2
Du, B; Kang, HYJ; Li, XY; Qiu, HB; Sun, B; Tong, ZH; Wang, F; Wang, YS; Zhan, X1
Hsueh, PR; Hsueh, SC; Ko, WC; Lai, CC; Liu, YH; Wang, CY; Wang, YH; Yen, MY1
Duan, Y; Zhou, C; Zhu, HL1
Carradori, S1
Atluri, S; Hirsch, JA; Manchikanti, L1
Cohen, J; Kupferschmidt, K1
Reina, J1
Ceccarelli, F; Conti, F; Di Franco, M; Spinelli, FR1
Chang, YL; Chen, MY; Lee, WS; Lu, CC1
Chan, MCW; Chen, D; Cheung, PP; Choy, KT; Chu, DKW; Huang, X; Hui, KPY; Kaewpreedee, P; Peiris, M; Sia, SF; Wong, AY; Yen, HL1
Agostini, ML; Baric, RS; Bluemling, GR; Brown, AJ; Chappell, JD; Denison, MR; Dinnon, KH; George, AS; Graham, RL; Harcourt, J; Hill, CS; Hughes, TM; Kolykhalov, AA; Leist, SR; Lu, X; Montgomery, SA; Natchus, MG; Painter, G; Pruijssers, AJ; Saindane, M; Schäfer, A; Sheahan, TP; Sims, AC; Stevens, LJ; Swanstrom, R; Tamin, A; Thornburg, NJ; Zhou, S1
Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA1
Ahmed, S; Asperges, E; Bernett, J; Brainard, DM; Cao, H; Castagna, A; Chelliah, D; Chen, D; Chihara, S; Childs, R; Chokkalingam, A; Cohen, SH; Cunningham, J; D'Arminio Monforte, A; Desai, P; DeZure, A; Diaz, G; Elboudwarej, E; Feldt, T; Flanigan, T; Gaggar, A; Green, G; Green, ML; Grein, J; Henne, I; Ismail, S; Kato, H; L'Her, E; Lapadula, G; Lescure, FX; Maeno, T; Majumder, S; Massari, M; Mera, R; Mora-Rillo, M; Mutoh, Y; Myers, RP; Nguyen, D; Nicastri, E; Oda, R; Ohmagari, N; Osinusi, AO; Quiros-Roldan, E; Redinski, J; Sellers, S; Shin, D; Studemeister, A; Tan, SK; Telep, L; Timbs, L; Verweij, E; Winterbourne, L; Yo, K; Zhao, Y; Zhong, L; Zoufaly, A1
Kirchdoerfer, RN1
Bottega, A; da Rosa, TF; Foletto, VS; Hörner, A; Hörner, R; Serafin, MB1
Belfer, JJ; Bondici, A; Dumkow, LE; Hillaker, E; Murad, H1
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM1
Arora, N; Banerjee, AK1
Avery, RK; Boyarsky, BJ; Durand, CM; Garonzik-Wang, JM; Getsin, SN; Jackson, KR; Kernodle, AB; Massie, AB; Po-Yu Chiang, T; Segev, DL; Van Pilsum Rasmussen, SE; Werbel, WA1
Alvarez, K; Canard, B; Decroly, E; Eydoux, C; Ferron, F; Guillemot, JC; Le, NT; Peersen, O; Selisko, B; Shannon, A1
Şimşek Yavuz, S; Ünal, S1
Costanzo, M; De Giglio, MAR; Roviello, GN1
Lal, A; Mishra, AK; Sahu, KK1
Bergan, S; Elens, L; Hesselink, DA; Langman, LJ; Lemaitre, F; Moes, DJAR; Molinaro, M; Venkataramanan, R1
Gangadaran, P; Jogalekar, MP; Veerabathini, A1
Hsueh, PR; Jean, SS; Lee, PI1
Al-Saffar, F; Cruz, D; Fan, A; Gaynor, P; Hsu, JJ; Kamath, M; Nsair, A1
Aryal, D; Beane, A; Dondorp, AM; Hayat, M; Schultz, MJ1
Ge, J; Li, H; Liu, Z1
Aronson, JK; Ferner, RE1
Beard, T; Cowan, M; Manning, TJ; Thomas-Richardson, J1
Aaron, JG; Arcasoy, S; Aversa, MM; Benvenuto, LJ; Brown, RS; Cohen, DJ; Dadhania, DM; Dove, LM; Dube, GK; Emond, JC; Farr, MA; Husain, SA; Kapur, S; Kodiyanplakkal, RP; Miko, BA; Mohan, S; Pereira, MR; Ratner, LE; Rosenblatt, RE; Samstein, B; Satlin, M; Small, CB; Tsapepas, DS; Uriel, N; Verna, EC; Walsh, TJ1
Ledford, H4
Augustin, M; Hallek, M; Nitschmann, S2
Alkindi, N; Mazer-Amirshahi, M; Mehta, N; Pourmand, A1
Ahsan, W; Alhazmi, HA; Bratty, MA; Javed, S; Najmi, A1
Ardura, M; Auletta, JJ; Dandoy, C; Hartley, D; Jaglowski, S; Lehmann, L1
Kao, JH; Su, TH1
Jeevaratnam, K1
Dai, J; Huang, J; Jiang, H; Li, C; Li, R; Li, X; Liu, B; Ma, Q; Pan, W; Shi, Y; Wang, Z; Xie, Y; Yang, Z; Zhao, J; Zheng, K1
Antonucci, M; Avataneo, V; Cusato, J; D'Avolio, A; de Nicolò, A; di Perri, G; Lamorde, M; Manca, A; Palermiti, A; Waitt, C; Walimbwa, S1
Delang, L; Neyts, J1
Ballout, RA; Bukrinsky, MI; Remaley, AT; Sviridov, D1
Fang, Y; Meng, XM; Ni, WJ; Shen, AZ; Xu, T; Zhou, H1
Cao, D; Li, C; Li, G; Li, Z; Sun, R; Wang, X1
Baden, LR; Morrissey, S; Rubin, EJ4
Kiessling, L; MacLaughlin, C; Sattin, S1
Douedi, S; Miskoff, J1
Coumou, J; de Vries, PJ1
Gadebusch Bondio, M; Marloth, M1
Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D1
Baggett, MV; Rhee, EP; Shepard, JO; Sise, ME; Stevens, JS1
Ferguson, J; Gumma, M; Kappagoda, S; Quintero, O; Rogers, A; Rosser, JI; Scott, J; Subramanian, A1
Boucher, HW; Ison, MG; Wolfe, C1
Aldrich, M; Cabana, MD; Chao, JY; Derespina, KR; Goldman, DL; Herold, BC; Medar, SS; Ushay, HM; Weingarten, J1
Angeli, E; Antinori, S; Bonazzetti, C; Borghi, B; Castelli, A; Coen, M; Colombo, R; Corbellino, M; Cossu, MV; Galli, M; Giacomelli, A; Giorgi, R; Gismondo, MR; Gubertini, G; Magni, C; Meroni, L; Milazzo, L; Mileto, D; Oreni, L; Pagani, G; Pellicciotta, M; Rech, R; Ridolfo, AL; Rizzardini, G; Rusconi, S; Torre, A; Vimercati, S1
Bonovas, S; Piovani, D1
Fätkenheuer, G; Lundgren, J1
Hoffmann, C1
Lai, T; Wu, B; Wu, J1
Brainard, D; Grein, J; Myers, RP1
Scudellari, M1
Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R1
Jia, X; Kai, G; Li, L; Nile, A; Nile, SH; Qiu, J1
Stuebe, A1
Carugati, M; Castaldo, G; Faccioli, P; Franzetti, M; Iemoli, E; Longoni, E; Molteni, C; Ormas, V; Pandolfo, A; Piconi, S; Pozzetti, U1
Estella, Á; Garnacho-Montero, J1
Norrie, JD1
Cao, B; Cao, L; Cheng, Z; Ding, D; Du, G; Du, R; Fan, G; Fu, S; Gao, L; Gu, X; Guo, T; Hayden, FG; Horby, PW; Hu, Y; Jaki, T; Jiang, Y; Jin, Y; Li, H; Liu, B; Liu, Z; Lu, Q; Lu, Y; Luo, G; Mei, C; Qin, H; Ruan, S; Shang, L; Tang, X; Wan, Y; Wang, A; Wang, C; Wang, K; Wang, S; Wang, Y; Wu, F; Xu, J; Yang, C; Yang, J; Ye, X; Ye, Y; Yin, W; Zhang, D; Zhang, Y; Zhao, J; Zhou, F1
Marto, N; Monteiro, EC1
Aggarwal, G; Aggarwal, S; Bangalore, S; Henry, BM1
Cattaneo, D; Clementi, E; Corbellino, M; Galli, M; Gervasoni, C; Riva, A1
Ahmad, SI1
Gottlieb, M; Hicks, C; Liang, SY; Long, B; Rosenberg, H1
Bhattacharya, M; Chakraborty, C; Lee, SS; Saha, A; Sharma, AR; Sharma, G1
Atmar, RL; Babiker, AG; Beigel, JH; Benfield, T; Bonnett, T; Burgess, TH; Chu, HY; Creech, CB; Dierberg, K; Dodd, LE; Fätkenheuer, G; Finberg, RW; Green, M; Hohmann, E; Hsieh, L; Kalil, AC; Kline, S; Kortepeter, MG; Lane, HC; Lopez de Castilla, D; Luetkemeyer, A; Lundgren, J; Lye, DC; Makowski, M; Mehta, AK; Nayak, S; Neaton, JD; Oh, MD; Ohmagari, N; Osinusi, A; Paredes, R; Patterson, TF; Pett, S; Ruiz-Palacios, GM; Short, WR; Sweeney, DA; Tapson, V; Tomashek, KM; Touloumi, G; Zingman, BS1
Atzrodt, CL; Clements, TP; Maknojia, I; McCarthy, RDP; Oldfield, TM; Po, J; Stepp, HE; Ta, KTL1
Dresser, LD; Jorgensen, SCJ; Kebriaei, R1
Cao, B; Cheng, Z; Du, G; Du, R; Fan, G; Fu, S; Gao, L; Hayden, FG; Horby, PW; Hu, Y; Jaki, T; Jin, Y; Liu, W; Liu, Y; Lu, Q; Lu, Y; Luo, G; Ruan, S; Wang, C; Wang, K; Wang, Y; Zhang, D; Zhang, Y; Zhao, J; Zhou, F1
Sun, D1
Dolin, R; Hirsch, MS1
Ahn, MY; Blair, C; Brainard, DM; Bruno, R; Cao, H; Chen, YS; Diaz, G; Gaggar, A; Galli, M; Goldman, JD; Hui, DS; Hyland, RH; Lye, DCB; Marks, KM; Marty, FM; Montejano, R; Mullane, KM; Muñoz, J; Nahass, RG; Osinusi, AO; SenGupta, D; Spinner, CD; Subramanian, A; Tashima, KT; Towner, WJ; Wei, X1
Davies, M; Dhanda, S; Evans, A; Lane, S; Osborne, V; Roy, D; Shakir, S1
Jain, S; Jolly, T; Mansuri, Z; Shah, B; Zafar, MK1
Beh, DLL; Chew, N; Ngiam, JN; Poh, KK; Sia, CH1
Gupta, P; Kumar, A; Narasimha Kumar, GV; Prajapati, S; Sharma, M1
Bohula, EA; Lang, JP; Morrow, DA; Moura, FA; Siddiqi, HK; Wang, X1
Campos, L; Gouveia, CC1
Balevic, SJ; Benjamin, DK; Cohen-Wolkowiez, M; Gonzalez, D; Hornik, CD; Hornik, CP; Maharaj, AR; Smith, PB; Wu, H; Zimmerman, KO1
Andreou, A; Filippou, D; Sipsas, N; Trantza, S; Tsiodras, S1
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A1
Gebrie, D; Getnet, D; Manyazewal, T1
Islam, T; Nasir, M; Parveen, RA; Saha, SK; Selina, F; Talha, KA1
Adamsick, ML; Bhattacharyya, RP; Bidell, MR; Elshaboury, RH; Gandhi, RG; Kim, AY; Nigwekar, S; Rhee, EP; Sise, ME1
Benfiels, T; Jensen, TØ; Johansen, IS; Lundgren, J; Nielsen, H; Wiese, L; Østergaard, L1
Anzick, S; Barbian, K; Bosio, CM; Cihlar, T; de Wit, E; Feldmann, F; Hanley, PW; Leighton, I; Lovaglio, J; Martens, C; Meade-White, K; Munster, VJ; Okumura, A; Pérez-Pérez, L; Porter, DP; Saturday, G; Schulz, J; Schwarz, B; Scott, DP; van Doremalen, N; Williamson, BN; Yinda, CK1
Fumeaux, T1
Asudani, D; Bouland, D; Gupta, V; Kwak, K; Segar, S; Taplitz, R; Torriani, F1
Chen, D; Dong, L; Pan, X; Peng, C; Yang, L1
Di Perri, G1
Yoo, JH1
Bamford, A; Brierley, J; Frauenfelder, C; Perucca, G; Whittaker, E1
Di Pasquale, G; Maggioni, AP1
Abrams-Downey, A; Saabiye, J; Vidaurrazaga, M1
Hui, N; Li, H; Liang, C; Liu, Y; Qiao, G; Shi, Z; Tang, Y; Tian, L; Xie, X; Zhang, D; Zhao, X1
Ahn, BY; Choe, PG; Kang, CK; Kim, NJ; Oh, MD; Park, SW; Park, WB; Seo, JD; Song, SH1
Chan, R; Kuo, CR; Lipworth, B1
Besari, A; Lee, YY; Omar, SFS; Thalha, AMM1
Magro, G1
Alvarez, JC; Annane, D; Etting, I; Larabi, IA; Moine, P1
Gafarova, AR; Gainullina, EN; Timerbulatov, SV; Timerbulatov, VM; Timerbulstov, MV1
Angus, DC; White, DB1
Kaltenboeck, A; Kesselheim, AS; Sarpatwari, A1
Cooke, G; Costelloe, CE; Daunt, A; Hauck, K; Liew, F; Nayagam, S; Perez-Guzman, PN; Thursz, MR1
Jin, H; Yin, G; Zhang, C1
Cao, H; Chng, E; German, P; Humeniuk, R; Ling, J; Mathias, A; Osinusi, A; Shen, G; Vu, A1
Li, C; Ren, L; Wang, L1
Brandt, N; Chou, J1
Amenta, F; Nittari, G; Pallotta, G; Tayebati, SK1
Agrati, C; Ascoli Bartoli, T; Avataneo, V; Capobianchi, MR; Caputi, P; Castilletti, C; D'Avolio, A; Forini, O; Ippolito, G; Lalle, E; Marchioni, L; Nicastri, E; Notari, S; Scorzolini, L; Tempestilli, M1
Abraham, OC; John, R; Karthik, R; Manesh, A; Varghese, GM1
Ali, A; Ali, SS; Babar, Z; Hamayun, F; Khan, A; Khan, AA; Khan, M; Saleem, S; Sardar, Z; Wei, DQ1
Burwick, RM; Glucksman, L; Naqvi, M; Smithson, S; Zakowski, P1
Bouadma, L; Deconinck, L; Dubert, M; Ghosn, J; Houhou-Fidouh, N; Isernia, V; Kramer, L; Le Hingrat, Q; Le Pluart, D; Lescure, FX; Patrier, J; Rioux, C; Visseaux, B; Wicky, PH; Yazdanpanah, Y1
Azmy, V; Benson, J; Love, K; Steele, R1
Chakraborty, A; Hosoki, K; Sur, S1
Danta, CC1
Agostinis, P; Carafoli, E; Li, X; Melino, G; Rabson, A; Shi, Y; Sun, E; Wang, Y1
Cleland, E; Giovane, RA; Henderson, CE; Rezai, S1
Gillenwater, S; Hadeh, A; Rahaghi, F1
McMahon, JH; Peleg, AY; Udy, A1
Kim, DH; McCaw, ZR; Wei, LJ1
Olalla, J1
Beigel, JH; Dodd, LE; Tomashek, KM1
Ancliff, P; Badle, S; Bamford, A; Bartram, J; Brierley, J; Cheng, D; Dalton, C; Dexter, D; Dixon, G; Du Pré, P; Ghorashian, S; Grandjean, L; Mittal, P; O'Connor, D; Orf, K; Pavasovic, V; Rao, A; Rogosic, S; Samarasinghe, S; Vora, A1
Abi Jaoude, J; El Alam, MB; Garcia Garcia, CJ; Kouzy, R; Ludmir, EB; Taniguchi, CM1
Allen, JM; Bakare, LS1
Dizaye, K; Marouf, BH1
Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A1
Li, Z; Liu, Y; Wang, D1
Donato, AA; Paladugu, S1
Foo, R; Thum, T; Wang, Y1
Azevedo, PCP; Azevedo, TCP; Barbosa, FT; Carvalho, ARVS; Cezarotti Filho, ML; Matos-Rocha, TJ; Ramos, FWDS; Silveira Filho, RN; Sousa-Rodrigues, CF1
Arcobello, J; Bakouny, Z; Choueiri, TK; de Lima Lopes, G; Doroshow, DB; Egan, PC; Farmakiotis, D; Fecher, LA; Friese, CR; Galsky, MD; Goel, S; Grivas, P; Gupta, S; Halfdanarson, TR; Halmos, B; Hawley, JE; Hsu, CY; Khaki, AR; Kuderer, NM; Lee, BJ; Lemmon, CA; Lyman, GH; Mishra, S; Olszewski, AJ; Painter, CA; Panagiotou, OA; Pennell, NA; Peters, S; Puc, MM; Revankar, SG; Rini, BI; Rivera, DR; Rubinstein, SM; Schapira, L; Schmidt, A; Schwartz, GK; Shah, DP; Shah, SA; Shyr, Y; Thompson, MA; Warner, JL; Wu, JT; Xie, Z; Yeh, AC; Zhu, H1
Helleberg, M; Kirk, O; Lane, C; Lebech, AM; Lundgren, J; Moestrup, KS; Niemann, CU1
Albrecht, R; Benner, C; Burgstaller-Muehlbacher, S; Cao, J; Chan, JF; Chanda, SK; Chang, MW; Chapman, ME; Chatterjee, AK; Cheng, K; Choi, A; De Jesus, PD; Dejosez, M; García-Sastre, A; Glynne, RJ; Herbert, KM; Hull, MV; Johnson, JR; Lendy, EK; Liu, WC; Martin-Sancho, L; Martinez-Sobrido, L; Matsunaga, N; Mesecar, AD; Miorin, L; Nguyen, C; Nguyen, TH; Pache, L; Poon, VK; Pu, Y; Rathnasinghe, R; Riva, L; Rubanov, A; Ruppin, E; Schotsaert, M; Schultz, PG; Sit, KY; Su, AI; Sun, R; Teriete, P; White, KM; Yin, X; Yuan, S; Yuen, KY; Zwaka, TP1
Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E1
Carvalho Junior, RN; J C Neto, AM; Martins, AY; Reis, AF; S Costa, JF; Silva Arouche, TD1
Durrieu, G; Montastruc, F; Thuriot, S1
Abd Ellah, NH; E Batiha, G; Gad, SF; Hetta, HF; Muhammad, K1
Andini, R; Bertolino, L; Corcione, A; De Rosa, R; Durante-Mangoni, E; Florio, LL; Galdo, M; Mele, F; Zampino, R1
Aly, B; Baron, DA; Blodget, E; Hashemi, A; Kouyoumjian, S; Musa, A; Pendi, K; Stevens, S; Warbasse, E; Yousif, J1
Martín Mateos, RM; Téllez, L1
Kääb, S; Kellnar, A; Stark, K; Stremmel, C; Weckbach, LT1
Agarwal, A; Agoritsas, T; Azab, M; Bartoszko, JJ; Bravo, G; Brignardello-Petersen, R; Chu, DK; Couban, R; Devji, T; Escamilla, Z; Foroutan, F; Gao, Y; Ge, L; Ghadimi, M; Guyatt, GH; Han, MA; Heels-Ansdell, D; Honarmand, K; Hou, L; Ibrahim, Q; Izcovich, A; Khamis, A; Kum, E; Lam, B; Lamontagne, F; Loeb, M; Mansilla, C; Marcucci, M; Martinez, JPD; McLeod, SL; Miroshnychenko, A; Motaghi, S; Murthy, S; Mustafa, RA; Pardo-Hernandez, H; Qasim, A; Rada, G; Rizwan, Y; Saadat, P; Siemieniuk, RA; Switzer, C; Thabane, L; Tomlinson, G; Vandvik, PO; Vernooij, RW; Viteri-García, A; Wang, Y; Yao, L; Zeraatkar, D; Zhao, Y1
Agarwal, A; Agoritsas, T; Appiah, JA; Bartoszko, J; Brignardello-Petersen, R; Ergan, B; Ge, L; Geduld, H; Gershengorn, HB; Guyatt, G; Huang, M; Kanda, S; Kawano-Dourado, L; Kurian, L; Kwizera, A; Lamontagne, F; Leo, YS; Manai, H; Murthy, S; Qadir, N; Rochwerg, B; Siemieniuk, R; Silvestre, MA; Vandvik, PO; Ye, Z; Zeng, L; Zeraatkar, D1
Saitz, R; Schwitzer, G1
Bu, Z; Ge, J; He, X; Hua, R; Liu, R; Shan, D; Shuai, L; Sun, Z; Wang, C; Wang, J; Wang, X; Wen, Z; Zhang, X; Zhong, G1
Baombe, JP1
Mendes, A1
Li, N; Li, Y; Yu, X1
Gan, W; Gu, J; Li, H; Li, Y; Lu, C; Luo, P; Miao, H; Tian, M; Wang, J; Wang, S; Wu, M; Yao, Y; Yuan, B; Zhao, D; Zhao, X1
Aziz, N; Bianco, K; Blackburn, BG; El-Sayed, YY; Grant, P; Igbinosa, I; Kappagoda, S; Lyell, DJ; Miller, S; Nelson, J; Subramanian, A1
Al-Yamani, MJ; Asdaq, SMB; Jomah, S1
Ijaz, M; Khan, M; Kharaba, ZJ; Murtaza, G; Shamim, S1
Bugiera, L; Grodd, M; Hazard, D; Kaier, K; Lambert, J; von Cube, M; Wolkewitz, M1
Bigley, AN; Narindoshvili, T; Raushel, FM1
Alvaro-Gracia, JM; Blanco, R; Carmona, L; Castrejón, I; Fernández Fernández, D; Fernandez-Nebro, A; Galindo, M; Gonzalez-Gay, MA; Lledó, A; Manrique-Arija, S; Martinez-Lopez, D; Mena Vázquez, N; Mera-Varela, A; Pablos, JL; Retuerto, M1
Chua, KP; Conti, RM1
Baysson, H; Beaune, G; Bing, F; Bonardel, C; Bonnerot, M; Chanzy, B; Combes, I; Cornut, L; Farines, M; Ludwig, M; Macheda, G; Vadot, W1
Hadda, V; Misra, S; Nath, M; Vibha, D1
Farhadi, T; Hashemian, SM; Velayati, AA1
Angus, DC; McCreary, EK1
Ahn, MY; Arribas López, JR; Bernasconi, E; Bhagani, S; Blair, C; Brainard, DM; Cao, H; Castagna, A; Cattelan, AM; Chai, LYA; Chang, SC; Criner, GJ; Gaggar, A; Gottlieb, RL; Huhn, G; Hyland, RH; Le Turnier, P; Malhotra, P; Marty, FM; McPhail, MJ; Mullane, KM; Ogbuagu, O; Osinusi, AO; Roestenberg, M; Sanyal, AJ; SenGupta, D; Soriano Viladomiu, A; Spinner, CD; Tsang, OTY; Wang, H1
Briasoulis, A; Kuno, T; Takagi, H; Yokoyama, Y1
Barchiesi, F; Canovari, B; Mancini, M; Montalti, R; Pasquini, Z; Pimpini, D; Temperoni, C; Tempesta, M; Zallocco, N1
Bliton, MJ; Weber, E1
Adewale, OB; Akanbi, MO; Bakare, OO; Fadaka, AO; Klein, A; Madiehe, AM; Meyer, M; Sibuyi, NRS1
Barfuss, P; Demirbag, S; Khan, KS; Le, TK; Ng, WL; Paris, C; Robson, F; Rocchi, P1
Baker, JV; DeBruin, DA; Kesler, S; Kline, S; Leider, JP; Lim, S; Lynfield, R; Rizza, S; Sederstrom, N; Sharp, RR; Wolf, SM; Wu, J1
Filipova, E; Pavlova, V; Uzunova, K; Vekov, T1
Bhagani, S; Pollara, G; Richardson, C1
Shih, WJ; Xie, T; Yao, C1
Bunel, V; Descamps, D; Jaquet, P; Le Hingrat, Q; Lê, MP; Mal, H; Massias, L; Messika, J; Peytavin, G; Timsit, JF; Visseaux, B; Wicky, PH1
Lamb, YN1
Kay, AW; Mandalakas, AM; Martinez, L; Ness, TE1
Gonzales-Zamora, JA; Quiroz, T; Vega, AD1
Green, RJ; Mustafa, F; Richards, GA; Sewlall, N1
Dobrovolny, HM1
Doggrell, SA1
Gohh, R; Merhi, B1
Hasslboeck, C; Kishioka, Y; Kweder, SL; Saint-Raymond, A; Sato, J; Teixeira, T1
Arthur, CM; Clarke, S; Josephson, CD; Lough, C; MacDonald, H; Roback, JD; Rodriguez, Z; Shane, AL; Stowell, SR; Suthar, M; Verkerke, H; Wolf, M; Wrammert, J; Zimmerman, MG1
Shilatifard, A1
Hansen, PR; Jürgens, G; Rasmussen, HB; Taboureau, O; Thomsen, R1
Ader, F1
Gupta, SP1
Alshaeri, HK; Natto, ZS1
Bai, YX; Guo, Y; Ma, KW; Qiu, S; Sun, C; Wang, X; Xu, YH1
Perišić, O1
Ata, O; Inci, TG; Kocer, S; Mutlu, O; Sariyer, E; Turgut-Balik, D; Ugurel, E; Ugurel, OM1
Emanuela, C; Francesco, L; Giorgia, G; Pasquale, N; Roberto, P; Sara, D1
Dzhafer, N; Papathanasiou, JV1
Glaus, MJ; Von Ruden, S1
Adimora, AA; Cole, SR; Edwards, JK1
Cui, JJ; Guo, CX; Ouyang, QY; Wang, LY; Yin, JY; Zhan, Y1
Cao, B; Gu, X; Wang, C; Wang, Y; Xu, J1
Gómez-Moreno, G1
Avorn, J; Darrow, JJ; Kesselheim, AS; Lee, CC1
Chien, M; Jockusch, S; Ju, J; Kalachikov, S; Kumar, S; Li, X; Morozova, I; Russo, JJ; Tao, C1
Goldust, M; Sandhu, S; Schwartz, RA; Sharma, A; Szepietowski, JC1
Baric, RS; Cooley, MR; Currie, CG; Dinnon, KH; Edwards, CE; Graham, RL; Gully, K; Hou, YJ; Leist, SR; Randell, SH; Scobey, TD; Sims, AC; Swanstrom, J; Yount, BL1
Fätkenheuer, G; Malin, JJ; Priesner, V; Rybniker, J; Suárez, I1
Gupta, J; Gupta, S; Kaushik, A1
Garg, NK; Knapp, RR; Okada, T; Sarpong, R; Tona, V1
Ali, K; Mallah, H; Maveddat, A; Nugent, K; Rao, S; Sherali, S1
Pathania, S; Rawal, RK; Singh, PK1
Chou, JT; Hana, D; Kaczmarek, M; Khalaf, K; Mackiewicz, A; Papp, N1
Farley, TM; Sabers, AJ; Williams, AL1
Aleissa, MM; Marty, FM; Nutt, CT; Paredes Acosta, LM; Richterman, A; Silverman, EA1
Alabed, SJ; Dahabiyeh, LA; Daoud, S1
Niburski, K; Niburski, O1
Arbustini, E; Bergomi, P; Bozzini, S; Cavagna, L; Colombo, R; Corsico, AG; Cova, E; D'Amato, M; Di Toro, A; Fossali, T; Frangipane, V; Lettieri, S; Lilleri, D; Meloni, F; Mojoli, F; Morosini, M; Ottolina, D; Pandolfi, L; Percivalle, E; Saracino, L; Tomaselli, S; Urtis, M1
Mishra, SK; Tripathi, T1
Chen, CH; Liu, HY; Pan, MY1
Cheng, J; Gao, L; Liu, H; Pan, X; Wang, L; Wu, D; Yan, Z; Yao, X; Zhang, Y; Zhu, Q1
Dolgin, E1
Bjørås, M; Byun, SY; Chang, SY; Choi, I; Ianevski, A; Kainov, DE; Ko, M; Min, JY; Pham Hung d'Alexandry d'Orengiani, AL; Ravlo, E; Shum, D; Wang, W; Windisch, MP1
Chow, VT; Chu, JJH; Tan, KSW; Tan, YL1
Adams, PL; Beigel, JH; El-Kamary, SS; Ince, WL; Krafft, A; Nam, HH; Sims, AC1
Baric, RS; Brown, AJ; Cihlar, T; Denison, MR; Dinnon, KH; Feng, JY; Graham, RL; Sheahan, TP; Sims, AC; Won, JJ1

Reviews

88 review(s) available for adenosine monophosphate and Infections, Coronavirus

ArticleYear
Understanding of COVID-19 based on current evidence.
    Journal of medical virology, 2020, Volume: 92, Issue:6

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Animals; Antiviral Agents; Betacoronavirus; China; Chiroptera; Communicable Disease Control; Coronavirus Infections; COVID-19; Disease Management; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Survival Analysis

2020
Clinical trial analysis of 2019-nCoV therapy registered in China.
    Journal of medical virology, 2020, Volume: 92, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Disease Management; Disease Outbreaks; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Pyrazines; SARS-CoV-2

2020
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Immunization, Passive; Interferon-beta; Lopinavir; Mice, Transgenic; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus

2020
[Pharmacotherapeutics for the new coronavirus pneumonia].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2020, Mar-12, Volume: 43, Issue:3

    Topics: Adenosine; Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antiviral Agents; China; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Humans; Lopinavir; Pneumonia, Viral; Retrospective Studies; Ribonucleotides; Ritonavir

2020
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3

    Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Alanine; Asymptomatic Infections; Betacoronavirus; China; Chloroquine; Comorbidity; Coronavirus Infections; COVID-19; Humans; Infection Control; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Young Adult

2020
[Remdesivir, the antiviral hope against SARS-CoV-2].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2020, Volume: 33, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Potential therapeutic agents against COVID-19: What we know so far.
    Journal of the Chinese Medical Association : JCMA, 2020, Volume: 83, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
    Pharmacotherapy, 2020, Volume: 40, Issue:5

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles

2020
Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin

2020
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA, 2020, May-12, Volume: 323, Issue:18

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment

2020
Antiviral treatment of COVID-19
    Turkish journal of medical sciences, 2020, 04-21, Volume: 50, Issue:SI-1

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles

2020
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
    Therapeutic drug monitoring, 2020, Volume: 42, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Interactions; Drug Monitoring; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; Protease Inhibitors; SARS-CoV-2; Transplant Recipients

2020
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
    Experimental biology and medicine (Maywood, N.J.), 2020, Volume: 245, Issue:11

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Communicable Disease Control; Coronavirus Infections; COVID-19; Genome, Viral; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; SARS-CoV-2; Serine Proteinase Inhibitors; Severe acute respiratory syndrome-related coronavirus

2020
Treatment options for COVID-19: The reality and challenges.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Teicoplanin

2020
Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings.
    The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Continuous Positive Airway Pressure; Coronavirus Infections; COVID-19; Developing Countries; Disease Management; Humans; Hydroxychloroquine; Lopinavir; Lung; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed

2020
Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Testing; COVID-19 Vaccines; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Immunization, Passive; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pyrazines; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Viral Vaccines

2020
[Remdesivir for patients with severe COVID-19].
    Der Internist, 2020, Volume: 61, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Severity of Illness Index

2020
Pharmacotherapy in COVID-19; A narrative review for emergency providers.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:7

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hydroxychloroquine; Interleukin-6; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; SARS-CoV-2

2020
Treatment of SARS-CoV-2: How far have we reached?
    Drug discoveries & therapeutics, 2020, May-06, Volume: 14, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferon-alpha; Interferon-beta; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2

2020
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020, Volume: 26, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Bone Marrow Transplantation; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Testing; Drug Combinations; Education, Distance; Hematopoietic Stem Cell Transplantation; Humans; Hydroxychloroquine; Immunization, Passive; Infection Control; Information Dissemination; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Real-Time Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tissue Donors

2020
Medical treatment options for COVID-19.
    European heart journal. Acute cardiovascular care, 2020, Volume: 9, Issue:3

    Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Recombinant Proteins; RNA, Viral; SARS-CoV-2

2020
Potential therapeutic targets and promising drugs for combating SARS-CoV-2.
    British journal of pharmacology, 2020, Volume: 177, Issue:14

    Topics: Adenosine Monophosphate; Alanine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Basigin; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Esters; Gabexate; Genome, Viral; Guanidines; Humans; Immunization, Passive; Immunosuppressive Agents; Medicine, Chinese Traditional; Nucleic Acid Synthesis Inhibitors; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; RNA-Dependent RNA Polymerase; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Viral Vaccines; Virus Internalization; Virus Replication

2020
Rapid review for the anti-coronavirus effect of remdesivir.
    Drug discoveries & therapeutics, 2020, Volume: 14, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus

2020
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
    Cytokine & growth factor reviews, 2020, Volume: 53

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Drug Therapy, Combination; Humans; Inflammation; Interferons; Oligonucleotides; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines

2020
Medicines for the Treatment Of COVID-19: Awaiting the Evidence.
    Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Investigational; Global Health; Humans; Hydroxychloroquine; Lopinavir; Off-Label Use; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.
    The American journal of cardiology, 2020, 08-01, Volume: 128

    Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Just the facts: What drugs are safe and effective for COVID-19?
    CJEM, 2020, Volume: 22, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Therapy; Humans; Male; Middle Aged; Needs Assessment; Pandemics; Patient Safety; Pneumonia, Viral; Risk Assessment; Severe Acute Respiratory Syndrome; Severity of Illness Index; Steroids; Treatment Outcome

2020
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    The FEBS journal, 2020, Volume: 287, Issue:17

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Drug Combinations; Humans; Hydroxychloroquine; Interferon beta-1a; Lopinavir; Middle East Respiratory Syndrome Coronavirus; Pandemics; Respiration, Artificial; Ritonavir; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Severity of Illness Index

2020
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19.
    Pharmacotherapy, 2020, Volume: 40, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
    Drug safety, 2020, Volume: 43, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Risk Assessment; SARS-CoV-2; Treatment Outcome

2020
Educational case series of electrocardiographs during the COVID-19 pandemic and the implications for therapy.
    Singapore medical journal, 2020, Volume: 61, Issue:8

    Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronavirus Infections; COVID-19; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Pandemics; Pneumonia, Viral; Sampling Studies; Severe Acute Respiratory Syndrome; Singapore; Treatment Outcome

2020
A current review of COVID-19 for the cardiovascular specialist.
    American heart journal, 2020, Volume: 226

    Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Biomarkers; Cardiovascular Diseases; Chloroquine; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Hypoxia; Pandemics; Plasma; Pneumonia, Viral; Receptor, Angiotensin, Type 2; Risk Factors; SARS-CoV-2; Takotsubo Cardiomyopathy; Virus Internalization

2020
Coronavirus Disease 2019: Clinical Review.
    Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment

2020
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
    In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl

    Topics: Acetylcysteine; Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Autophagy; Betacoronavirus; Colchicine; Copper; Coronavirus Infections; COVID-19; Cytidine; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxylamines; Inflammation; Nitric Oxide; Pandemics; Pneumonia, Viral; Prodrugs; Ribonucleosides; SARS-CoV-2; Virus Internalization; Virus Replication

2020
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl

    Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome

2020
Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences.
    Mymensingh medical journal : MMJ, 2020, Volume: 29, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2

2020
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.
    Journal of the American Society of Nephrology : JASN, 2020, Volume: 31, Issue:7

    Topics: Acute Kidney Injury; Adenosine Monophosphate; Alanine; Antiviral Agents; Cause of Death; Comorbidity; Coronavirus Infections; COVID-19; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Massachusetts; Pandemics; Pneumonia, Viral; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate

2020
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
    Virus research, 2020, Volume: 286

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Interferons; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis

2020
Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir.
    Pediatrics, 2020, Volume: 146, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Infant; Infant, Premature; Intensive Care Units; Intubation, Intratracheal; Pandemics; Patient Discharge; Pneumonia, Viral; Radiography, Thoracic; Respiration, Artificial; Severe Acute Respiratory Syndrome; Treatment Outcome

2020
[COVID-19 trials: surfing between expectations and illusions, looking forward to evidence].
    Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Italy; Male; Pandemics; Pneumonia, Viral; Prevalence; Randomized Controlled Trials as Topic; Risk Assessment

2020
Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.
    European urology focus, 2020, Sep-15, Volume: 6, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Pandemics; Pneumonia, Viral; Receptors, Interleukin-6; SARS-CoV-2

2020
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
    European journal of medicinal chemistry, 2020, Sep-01, Volume: 201

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Emerging pharmacotherapy for COVID-19.
    The journal of the Royal College of Physicians of Edinburgh, 2020, Volume: 50, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Enzyme Inhibitors; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    The journal of the Royal College of Physicians of Edinburgh, 2020, Volume: 50, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
    Virus research, 2020, Volume: 286

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Anticoagulants; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Drug Combinations; Heparin; Humans; Hydroxychloroquine; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Sulfonamides

2020
[Drug treatment of coronavirus disease COVID-19: evidence exists?]
    Khirurgiia, 2020, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tissue Plasminogen Activator

2020
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
    Virus research, 2020, Volume: 286

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Teicoplanin

2020
Current pharmacological treatments for SARS-COV-2: A narrative review.
    European journal of pharmacology, 2020, Sep-05, Volume: 882

    Topics: Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunity, Innate; Inflammation Mediators; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
Clinical management of COVID-19.
    The Indian journal of medical research, 2020, Volume: 151, Issue:5

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Airway Management; Alanine; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Critical Illness; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Shock; Specimen Handling; Symptom Assessment; Vulnerable Populations

2020
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    The Journal of allergy and clinical immunology, 2020, Volume: 146, Issue:2

    Topics: Adenosine Monophosphate; Age Factors; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Asthma; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Repositioning; Humans; Masks; Pandemics; Peptidyl-Dipeptidase A; Physical Distancing; Pneumonia, Viral; Prevalence; Quarantine; Receptors, Virus; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus

2020
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Antimicrobial agents and chemotherapy, 2020, 08-20, Volume: 64, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Treatment Outcome

2020
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection.
    ACS chemical neuroscience, 2020, 08-05, Volume: 11, Issue:15

    Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Blood-Brain Barrier; Brain; Central Nervous System Agents; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Humans; Methylprednisolone; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
Is hydroxychloroquine beneficial for COVID-19 patients?
    Cell death & disease, 2020, 07-08, Volume: 11, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Risk; SARS-CoV-2

2020
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Reviews in medical virology, 2020, Volume: 30, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Drug Repositioning; Esters; Gabexate; Gene Expression Regulation; Guanidines; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus

2020
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
    JAMA network open, 2020, 07-01, Volume: 3, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Biological Products; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Non-Randomized Controlled Trials as Topic; Pandemics; Pneumonia, Viral; Protease Inhibitors; Protein-Tyrosine Kinases; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Viral Load

2020
Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
    Drug discoveries & therapeutics, 2020, Volume: 14, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Journal of infection and public health, 2020, Volume: 13, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antimalarials; Antiviral Agents; Betacoronavirus; Biomedical Research; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Drug Development; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2

2020
Use of remdesivir for patients with Covid-19: a review article.
    Revista da Associacao Medica Brasileira (1992), 2020, Volume: 66, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
    The Journal of allergy and clinical immunology, 2020, Volume: 146, Issue:4

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index

2020
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
    Nanomedicine (London, England), 2020, Volume: 15, Issue:21

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Drug Repositioning; Host Microbial Interactions; Humans; Nanomedicine; Nanotechnology; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vaccines, Synthetic; Viral Vaccines

2020
Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature.
    The western journal of emergency medicine, 2020, May-20, Volume: 21, Issue:4

    Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
COVID-19 and liver disease: An update.
    Gastroenterologia y hepatologia, 2020, Volume: 43, Issue:8

    Topics: Adenosine Monophosphate; Age Factors; Alanine; Antiviral Agents; Betacoronavirus; Bile Ducts; Chemical and Drug Induced Liver Injury; Chronic Disease; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Gastroenterology; Health Resources; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Liver; Liver Diseases; Liver Function Tests; Liver Transplantation; Obesity; Pandemics; Pneumonia, Viral; Resource Allocation; Risk Factors; SARS-CoV-2

2020
Drug treatments for covid-19: living systematic review and network meta-analysis
    BMJ (Clinical research ed.), 2020, 07-30, Volume: 370

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Centers for Disease Control and Prevention, U.S.; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Drug Combinations; Evidence-Based Medicine; Glucocorticoids; Humans; Hydroxychloroquine; Lopinavir; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; Ritonavir; SARS-CoV-2; Severity of Illness Index; Standard of Care; Treatment Outcome; United States

2020
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Biomarkers; Child; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Drug Combinations; Early Diagnosis; Fever; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Ribavirin; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed

2020
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review.
    Journal of infection and public health, 2020, Volume: 13, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2

2020
Potential strategies for combating COVID-19.
    Archives of virology, 2020, Volume: 165, Issue:11

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Indoles; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Severity of Illness Index; Viral Vaccines

2020
Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis.
    European journal of clinical investigation, 2020, Volume: 50, Issue:11

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Europe; Female; Humans; Lopinavir; Male; Pandemics; Pneumonia, Viral; Prognosis; Ritonavir; Survival Analysis; Treatment Outcome

2020
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Virus Replication

2020
Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Virus research, 2020, 10-15, Volume: 288

    Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Administration Schedule; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome

2020
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
    The Journal of international medical research, 2020, Volume: 48, Issue:8

    Topics: Adenosine Monophosphate; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Communicable Disease Control; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Incidence; Pandemics; Personal Protective Equipment; Physical Distancing; Pneumonia, Viral; Quarantine; SARS-CoV-2; Severity of Illness Index; Survival Analysis

2020
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.
    Molecular cell, 2020, 09-03, Volume: 79, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytidine; Genome, Viral; Humans; Hydroxylamines; Molecular Targeted Therapy; Mutation; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleosides; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Transcription, Genetic; Viral Nonstructural Proteins; Virus Replication

2020
Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
    Mayo Clinic proceedings, 2020, Volume: 95, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drugs, Investigational; Health Care Rationing; Humans; Minnesota; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States; United States Food and Drug Administration

2020
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Remdesivir: First Approval.
    Drugs, 2020, Volume: 80, Issue:13

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Development; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
    Expert review of clinical pharmacology, 2020, Volume: 13, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Emergency Medical Services; European Union; Humans; Japan; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States

2020
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
    Current topics in medicinal chemistry, 2020, Volume: 20, Issue:26

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Gene Expression; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Immunization, Passive; Ivermectin; Models, Molecular; Niclosamide; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Vaccines

2020
A contemporary look at COVID-19 medications: available and potentially effective drugs.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Imatinib Mesylate; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Advances in SARS-CoV-2: a systematic review.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Immunization, Passive; Immunotherapy; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2

2020
Current treatment of COVID-19 in renal patients: hope or hype?
    Internal and emergency medicine, 2020, Volume: 15, Issue:8

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Drug Combinations; Humans; Kidney; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ritonavir

2020
Remdesivir-COVID-19: drug interactions in dentistry.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:18

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dentistry; Drug Interactions; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Systemic Medications of Dermatological Importance in COVID-19.
    Journal of drugs in dermatology : JDD, 2020, Sep-01, Volume: 19, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biological Products; Coronavirus Infections; COVID-19; Dermatologic Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Pandemics; Pneumonia, Viral; Prognosis; Risk Assessment; Severe Acute Respiratory Syndrome

2020
Remdesivir against COVID-19 and Other Viral Diseases.
    Clinical microbiology reviews, 2020, 12-16, Volume: 34, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Compassionate Use Trials; Coronavirus Infections; COVID-19; Drug Administration Schedule; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Patient Safety; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Survival Analysis; Treatment Outcome

2020
Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).
    The international journal of occupational and environmental medicine, 2020, Volume: 11, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Lung; Pandemics; Pneumonia, Viral; Positive-Pressure Respiration; Respiratory Distress Syndrome; SARS-CoV-2; United States

2020
SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal; Antibodies, Viral; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Reservoirs; Drug Repositioning; Humans; Immunoenzyme Techniques; Immunotherapy; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Serologic Tests; Spike Glycoprotein, Coronavirus

2020
Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection.
    BMJ case reports, 2020, Oct-31, Volume: 13, Issue:10

    Topics: Adenosine Monophosphate; Aged, 80 and over; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Emergency Service, Hospital; Humans; Length of Stay; Liver Diseases; Liver Function Tests; Male; Pandemics; Patient Discharge; Pneumonia, Viral; Respiratory Insufficiency; Severity of Illness Index; Treatment Outcome

2020
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19.
    Antimicrobial agents and chemotherapy, 2020, 12-16, Volume: 65, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Breast Feeding; Clinical Trials as Topic; Coronavirus Infections; COVID-19 Drug Treatment; Female; Humans; Immunocompromised Host; Middle East Respiratory Syndrome Coronavirus; Pregnancy; SARS-CoV-2

2020
One year update on the COVID-19 pandemic: Where are we now?
    Acta tropica, 2021, Volume: 214

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses

2021
Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.
    Antiviral research, 2019, Volume: 167

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; Humans; Influenza, Human; Pandemics; Respiratory Syncytial Virus, Human; Respiratory Tract Infections

2019

Trials

8 trial(s) available for adenosine monophosphate and Infections, Coronavirus

ArticleYear
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
    Pharmacological research, 2020, Volume: 158

    Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transaminases; Treatment Outcome

2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Lancet (London, England), 2020, 05-16, Volume: 395, Issue:10236

    Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Negative Results; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir for the Treatment of Covid-19 - Final Report.
    The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19

    Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Extracorporeal Membrane Oxygenation; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Time Factors; Young Adult

2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
    Trials, 2020, May-24, Volume: 21, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Equivalence Trials as Topic; Female; Humans; Infusions, Intravenous; Male; Multicenter Studies as Topic; Pandemics; Patient Safety; Pneumonia, Viral; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome

2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
    The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19

    Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects.
    Clinical and translational science, 2020, Volume: 13, Issue:5

    Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Alanine; Antiviral Agents; Area Under Curve; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Healthy Volunteers; Humans; Japan; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Young Adult

2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
    JAMA, 2020, 09-15, Volume: 324, Issue:11

    Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
    BMJ open, 2020, 09-21, Volume: 10, Issue:9

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Early Warning Score; Extracorporeal Membrane Oxygenation; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interferon beta-1a; Length of Stay; Lopinavir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; Ritonavir; SARS-CoV-2; Standard of Care; Treatment Outcome

2020

Other Studies

167 other study(ies) available for adenosine monophosphate and Infections, Coronavirus

ArticleYear
Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63.
    Molecules (Basel, Switzerland), 2021, Nov-11, Volume: 26, Issue:22

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Survival; Chlorocebus aethiops; Coronavirus Infections; Coronavirus NL63, Human; Emodin; Halogenation; Humans; Vero Cells

2021
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice.
    Communications biology, 2022, 03-18, Volume: 5, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Caco-2 Cells; Chlorocebus aethiops; Common Cold; Coronavirus Infections; Coronavirus OC43, Human; COVID-19 Drug Treatment; Cytokines; Drug Synergism; Humans; Isothiocyanates; Lung; Macrophages, Alveolar; Male; Mice, Transgenic; SARS-CoV-2; Spleen; Sulfoxides; T-Lymphocytes; Vero Cells; Viral Load

2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.
    Science translational medicine, 2022, 05-04, Volume: 14, Issue:643

    Topics: Adenosine; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Mice; Nucleosides; Parents; Prodrugs; SARS-CoV-2

2022
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view.
    Inflammopharmacology, 2022, Volume: 30, Issue:5

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19 Drug Treatment; Hospitalization; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2022
Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment.
    Journal of global health, 2022, Aug-31, Volume: 12

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Male; Pandemics; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; SARS-CoV-2

2022
Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection.
    Cell reports. Medicine, 2022, 09-20, Volume: 3, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19 Drug Treatment; Disease Progression; Humans; Pandemics; Pneumonia, Viral; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2

2022
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
    Nature communications, 2020, 01-10, Volume: 11, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Carboxylesterase; Coronavirus Infections; Drug Combinations; Drug Development; Female; Humans; Interferon-beta; Lopinavir; Lung Injury; Male; Mice; Mice, Knockout; Middle East Respiratory Syndrome Coronavirus; Ritonavir; Viral Load; Virus Replication

2020
Drug treatment options for the 2019-new coronavirus (2019-nCoV).
    Bioscience trends, 2020, Mar-16, Volume: 14, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Discovery; Humans; Lopinavir; Neuraminidase; Nucleosides; Pneumonia, Viral; Ribonucleotides; Ritonavir; SARS-CoV-2

2020
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
    Cell research, 2020, Volume: 30, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Animals; Antimalarials; Antiviral Agents; Betacoronavirus; Biological Assay; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Drug Evaluation, Preclinical; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Sincalide; Vero Cells

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Lung; Macaca mulatta; Male; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Post-Exposure Prophylaxis; SARS-CoV-2; Viral Load; Virus Replication

2020
More than 80 clinical trials launch to test coronavirus treatments.
    Nature, 2020, Volume: 578, Issue:7795

    Topics: Adenosine Monophosphate; Alanine; Animals; Anti-HIV Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dioxanes; Disease Models, Animal; Drug Combinations; Humans; Immunization, Passive; Lopinavir; Medicine, Chinese Traditional; Monosaccharides; Pandemics; Pneumonia, Viral; Registries; Ritonavir; SARS-CoV-2; Severe Acute Respiratory Syndrome; Stem Cell Transplantation; Steroids; Time Factors; Treatment Outcome; World Health Organization

2020
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
    Life sciences, 2020, May-01, Volume: 248

    Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Catalytic Domain; Computational Biology; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Molecular Docking Simulation; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Ribavirin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Sofosbuvir; Thermodynamics; Uridine Triphosphate; Viral Proteins

2020
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
    Nature reviews. Drug discovery, 2020, Volume: 19, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hepatitis B; Hepatitis C; HIV Infections; Humans; Influenza, Human; Interferon-alpha; Middle East Respiratory Syndrome Coronavirus; Nucleosides; Pneumonia, Viral; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus

2020
Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza.
    Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2020, Volume: 15, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Breast Feeding; Coronavirus Infections; COVID-19; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Milk, Human; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; DNA-Directed RNA Polymerases; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
    Drug discoveries & therapeutics, 2020, Volume: 14, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Studies as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Indoles; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleotides; SARS-CoV-2; Virus Replication

2020
Advance of promising targets and agents against COVID-19 in China.
    Drug discovery today, 2020, Volume: 25, Issue:5

    Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins

2020
Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2020, Volume: 19, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Chloroquine; Communicable Disease Control; Coronavirus Infections; COVID-19; Drug Discovery; Drug Repositioning; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Virus Internalization

2020
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Pain physician, 2020, Volume: 23, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Analgesia; Antiviral Agents; Betacoronavirus; China; Compassionate Use Trials; Cord Blood Stem Cell Transplantation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Critical Illness; Cytokines; Humans; Hydroxychloroquine; Mesenchymal Stem Cell Transplantation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Umbilical Cord; United States; Viral Vaccines

2020
Race to find COVID-19 treatments accelerates.
    Science (New York, N.Y.), 2020, 03-27, Volume: 367, Issue:6485

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Biomedical Research; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; World Health Organization

2020
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Antimalarials; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus

2020
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
    Antiviral research, 2020, Volume: 178

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antimetabolites; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Emetine; Epithelial Cells; Homoharringtonine; Humans; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; SARS-CoV-2; Vero Cells; Virus Replication

2020
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
    Science translational medicine, 2020, 04-29, Volume: 12, Issue:541

    Topics: Adenosine Monophosphate; Alanine; Animals; Antibiotic Prophylaxis; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; Cytidine; Disease Models, Animal; Drug Resistance, Viral; Humans; Hydroxylamines; Lung; Mice; Mice, Inbred C57BL; Middle East Respiratory Syndrome Coronavirus; Models, Molecular; Mutation; Pandemics; Pneumonia, Viral; Primary Cell Culture; Random Allocation; Respiratory System; Ribonucleosides; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Virus Replication

2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
    The New England journal of medicine, 2020, 06-11, Volume: 382, Issue:24

    Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Betacoronavirus; Canada; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Europe; Female; Humans; Japan; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; United States; Young Adult

2020
Halting coronavirus polymerase.
    The Journal of biological chemistry, 2020, 04-10, Volume: 295, Issue:15

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Coronavirus; Coronavirus Infections; Exonucleases; Humans; Pandemics; RNA-Dependent RNA Polymerase; Virus Replication

2020
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
    Pharmacotherapy, 2020, Volume: 40, Issue:6

    Topics: Adenosine Monophosphate; Adult; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Time Factors; Time-to-Treatment

2020
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Current topics in medicinal chemistry, 2020, Volume: 20, Issue:16

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Hand Hygiene; Humans; International Cooperation; Masks; Pandemics; Patient Education as Topic; Pneumonia, Viral; Quarantine; SARS-CoV-2; Viral Vaccines

2020
Early impact of COVID-19 on transplant center practices and policies in the United States.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Critical Illness; Evidence-Based Medicine; Health Policy; Humans; Hydroxychloroquine; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Living Donors; Organ Transplantation; Pandemics; Pneumonia, Viral; Resource Allocation; SARS-CoV-2; Surveys and Questionnaires; Tissue Donors; Transplant Recipients; United States

2020
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Antiviral research, 2020, Volume: 178

    Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; Betacoronavirus; Catalytic Domain; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Drug Resistance, Viral; Exoribonucleases; Humans; Models, Molecular; Mutation; Pandemics; Pneumonia, Viral; Protein Conformation; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Structure-Activity Relationship; Viral Nonstructural Proteins

2020
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Current medicinal chemistry, 2020, Volume: 27, Issue:27

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2

2020
COVID-2019: update on epidemiology, disease spread and management.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Apr-16, Volume: 90, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Basic Reproduction Number; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Quarantine; Receptors, Virus; SARS-CoV-2

2020
The race against COVID-19.
    Nature nanotechnology, 2020, Volume: 15, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Viral; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Humans; Hydroxychloroquine; Nucleic Acid Amplification Techniques; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines

2020
COVID-19 in a high-risk dual heart and kidney transplant recipient.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7

    Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Cardiomyopathy, Dilated; Coronavirus Infections; COVID-19; Heart Transplantation; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Randomized Controlled Trials as Topic; Risk Factors; SARS-CoV-2; Treatment Outcome

2020
Remdesivir in covid-19.
    BMJ (Clinical research ed.), 2020, 04-22, Volume: 369

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Ribonucleotides; SARS-CoV-2

2020
Some drugs for COVID-19.
    The Medical letter on drugs and therapeutics, 2020, 04-06, Volume: 62, Issue:1595

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Neuraminidase; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals.
    Drug discovery today, 2020, Volume: 25, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Aquatic Organisms; Biological Products; Chloroquine; Coronavirus Infections; COVID-19; Drug Compounding; Humans; Hydroxychloroquine; Models, Molecular; Pandemics; Pneumonia, Viral; Volatilization

2020
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7

    Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Female; Hospitalization; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Intensive Care Units; Intubation; Male; Middle Aged; New York City; Organ Transplantation; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Steroids; Transplant Recipients; Treatment Outcome; United States

2020
Chloroquine hype is derailing the search for coronavirus treatments.
    Nature, 2020, Volume: 580, Issue:7805

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
The clinical manifestations and management of COVID-19-related liver injury.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2020, Volume: 119, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Liver; Liver Diseases; Liver Function Tests; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
    European heart journal. Cardiovascular pharmacotherapy, 2020, 07-01, Volume: 6, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
    Pharmacological research, 2020, Volume: 158

    Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Proliferation; Cells, Cultured; Chlorocebus aethiops; Complex Mixtures; Coronavirus Infections; COVID-19; Humans; Inflammation Mediators; NF-kappa B; Pandemics; Pneumonia, Viral; SARS-CoV-2; Signal Transduction; Virion

2020
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.
    The Journal of antimicrobial chemotherapy, 2020, 07-01, Volume: 75, Issue:7

    Topics: Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Betacoronavirus; Chromatography, High Pressure Liquid; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sensitivity and Specificity; Tandem Mass Spectrometry

2020
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:6

    Topics: ADAM17 Protein; Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Benzylisoquinolines; Betacoronavirus; Biological Transport; Cathepsin L; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Endocytosis; Endosomes; Glycopeptides; Humans; Hydroxychloroquine; Intracellular Signaling Peptides and Proteins; Lysosomes; Membrane Lipids; Membrane Microdomains; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oxysterols; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Triazoles; Virus Internalization

2020
Audio Interview: Studying Potential Covid-19 Therapies.
    The New England journal of medicine, 2020, 05-07, Volume: 382, Issue:19

    Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Controlled Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2

2020
When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy.
    ACS chemical biology, 2020, 06-19, Volume: 15, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Biomedical Research; Chemistry; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Italy; Laboratories; Pandemics; Phylogeny; Pneumonia, Viral; SARS-CoV-2

2020
Novel coronavirus 2019 (COVID-19): A case report and review of treatments.
    Medicine, 2020, Volume: 99, Issue:19

    Topics: Adenosine Monophosphate; Aged; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Fatal Outcome; Female; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2

2020
[Chloroquine as a possible treatment for COVID-19].
    Nederlands tijdschrift voor geneeskunde, 2020, Mar-11, Volume: 164

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Lopinavir; Off-Label Use; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome

2020
[The "Historic Study" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].
    NTM, 2020, Volume: 28, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Bioethical Issues; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Editorial Policies; Humans; Hydroxychloroquine; International Cooperation; Lopinavir; Pandemics; Pneumonia, Viral; Research Design; Ritonavir; SARS-CoV-2; World Health Organization

2020
In Vitro Data of Current Therapies for SARS-CoV-2.
    Current medicinal chemistry, 2020, Volume: 27, Issue:27

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles

2020
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.
    The New England journal of medicine, 2020, May-28, Volume: 382, Issue:22

    Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Amides; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Betacoronavirus; Continuous Renal Replacement Therapy; Coronavirus Infections; COVID-19; Creatinine; Humans; Hypertension; Lung; Male; Obesity; Pandemics; Pneumonia, Viral; Pyrazines; Radiography, Thoracic; SARS-CoV-2

2020
Coronavirus drugs trials must get bigger and more collaborative.
    Nature, 2020, Volume: 581, Issue:7807

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Compassionate Use Trials; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
    Emerging infectious diseases, 2020, Volume: 26, Issue:8

    Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Asthma; Azithromycin; Betacoronavirus; California; Clinical Laboratory Techniques; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Intensive Care Units; Length of Stay; Male; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed

2020
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    JAMA, 2020, 06-16, Volume: 323, Issue:23

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Emergencies; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States

2020
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
    The Journal of pediatrics, 2020, Volume: 223

    Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Asthma; Betacoronavirus; Blood Urea Nitrogen; C-Reactive Protein; Child; Child, Preschool; Coronavirus Infections; COVID-19; Creatinine; Critical Illness; Dyspnea; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Natriuretic Peptide, Brain; New York City; Pandemics; Pediatric Obesity; Platelet Count; Pneumonia, Viral; Procalcitonin; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Sepsis; Shock, Septic; Tertiary Care Centers; Young Adult

2020
Dozens of coronavirus drugs are in development - what happens next?
    Nature, 2020, Volume: 581, Issue:7808

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Development; Drug Industry; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral

2020
Compassionate Use of Remdesivir in Covid-19.
    The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Compassionate Use of Remdesivir in Covid-19.
    The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Compassionate Use of Remdesivir in Covid-19.
    The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Compassionate Use of Remdesivir in Covid-19.
    The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Compassionate Use of Remdesivir in Covid-19. Reply.
    The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
The sprint to solve coronavirus protein structures - and disarm them with drugs.
    Nature, 2020, Volume: 581, Issue:7808

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Azoles; Betacoronavirus; China; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Papain-Like Proteases; Coronavirus RNA-Dependent RNA Polymerase; COVID-19 Vaccines; Cryoelectron Microscopy; Crystallization; Crystallography, X-Ray; Cysteine Endopeptidases; Drug Design; Drug Evaluation, Preclinical; Germany; High-Throughput Screening Assays; Humans; Isoindoles; Mice; National Institutes of Health (U.S.); Organoselenium Compounds; Peptidyl-Dipeptidase A; Protease Inhibitors; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Synchrotrons; Time Factors; United Kingdom; United States; Viral Nonstructural Proteins; Viral Proteins; Viral Vaccines

2020
Early experience with remdesivir in SARS-CoV-2 pneumonia.
    Infection, 2020, Volume: 48, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes

2020
Protect Pregnant and Lactating Women with COVID-19 Through Research, Not from Research.
    Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2020, Volume: 15, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Breast Feeding; Coronavirus Infections; COVID-19; Drug Approval; Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactation; Milk, Human; Pandemics; Pneumonia, Viral; Pregnancy; Risk Assessment; SARS-CoV-2

2020
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Middle Aged; Pandemics; Pneumonia, Viral; Receptors, Interleukin-1; Respiratory Insufficiency; SARS-CoV-2

2020
[From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].
    Medicina intensiva, 2020, Volume: 44, Issue:8

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Decision-Making; Clinical Trials as Topic; Coronavirus Infections; Cost-Benefit Analysis; COVID-19; Drug Combinations; Empiricism; Humans; Hydroxychloroquine; Information Dissemination; Lopinavir; Pandemics; Pneumonia, Viral; Reproducibility of Results; Ritonavir; SARS-CoV-2; Viral Load

2020
Remdesivir for COVID-19: challenges of underpowered studies.
    Lancet (London, England), 2020, 05-16, Volume: 395, Issue:10236

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Double-Blind Method; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2

2020
Does lopinavir really inhibit SARS-CoV-2?
    Pharmacological research, 2020, Volume: 158

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Emetine; Homoharringtonine; Humans; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus

2020
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection.
    Medical hypotheses, 2020, Volume: 142

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deoxyribonucleosides; Deoxyribose; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Inflammation; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.
    Archives of medical research, 2020, Volume: 51, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; RNA, Viral; SARS-CoV-2

2020
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    The AAPS journal, 2020, 05-26, Volume: 22, Issue:4

    Topics: Adenosine Monophosphate; Administration, Inhalation; Administration, Intravenous; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir - An Important First Step.
    The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Audio Interview: New Data on Remdesivir in Covid-19.
    The New England journal of medicine, 2020, 05-28, Volume: 382, Issue:22

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Evaluation; Humans; Hydroxychloroquine; Infusions, Intravenous; Pandemics; Placebos; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Time Factors; Treatment Outcome; Viral Load

2020
Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective.
    The primary care companion for CNS disorders, 2020, 05-28, Volume: 22, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Interactions; Humans; Pandemics; Pneumonia, Viral; Psychotropic Drugs; SARS-CoV-2

2020
An update on novel COVID-19 pandemic: a battle between humans and virus.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; RNA, Viral; SARS-CoV-2; Survival Analysis

2020
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.
    JAMA pediatrics, 2020, 10-01, Volume: 174, Issue:10

    Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antiviral Agents; Child; Child, Preschool; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Male; Models, Biological; Pandemics; Patient Simulation; Pneumonia, Viral; Therapies, Investigational; Young Adult

2020
Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
    BMJ open, 2020, 06-04, Volume: 10, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Infection Control; Meta-Analysis as Topic; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2; Systematic Reviews as Topic; Treatment Outcome

2020
[Remdesivir til behandling af COVID-19-pneumoni].
    Ugeskrift for laeger, 2020, 06-08, Volume: 182, Issue:24

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Nature, 2020, Volume: 585, Issue:7824

    Topics: Adenosine Monophosphate; Alanine; Animals; Betacoronavirus; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Disease Models, Animal; Disease Progression; DNA Mutational Analysis; Drug Resistance, Viral; Female; Lung; Macaca mulatta; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Secondary Prevention; Time Factors; Viral Load; Virus Replication; Virus Shedding

2020
    Revue medicale suisse, 2020, 06-10, Volume: 16, Issue:697

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Humans; Negative Results; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Flight of the COVID-19 patient: experience with a Wuhan evacuee: a case report.
    Journal of medical case reports, 2020, Jun-11, Volume: 14, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Blood Cell Count; California; China; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Transmission, Infectious; Female; Humans; Liver Function Tests; Middle Aged; Pandemics; Pneumonia, Viral; Quarantine; Radiography, Thoracic; SARS-CoV-2; Treatment Outcome

2020
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
    Le infezioni in medicina, 2020, 06-01, Volume: 28, Issue:suppl 1

    Topics: Adenosine Monophosphate; Alanine; Anticoagulants; Antiviral Agents; Biomarkers; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Disease Management; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Embolism; Endothelium, Vascular; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Interferon beta-1b; Lopinavir; Macrophage Activation; Pandemics; Pneumonia, Viral; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Ritonavir; Thromboembolism; Thrombophilia; Thrombosis

2020
Uncertainty about the Efficacy of Remdesivir on COVID-19.
    Journal of Korean medical science, 2020, Jun-15, Volume: 35, Issue:23

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Pandemics; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Uncertainty; Virus Replication

2020
Coronavirus breakthrough: dexamethasone is first drug shown to save lives.
    Nature, 2020, Volume: 582, Issue:7813

    Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Dexamethasone; Humans; Pandemics; Pneumonia, Viral; Preprints as Topic; Randomized Controlled Trials as Topic; Respiration, Artificial; Risk Assessment; Survival Rate

2020
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Journal of Korean medical science, 2020, Jun-22, Volume: 35, Issue:24

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Primary Prevention; SARS-CoV-2

2020
[Remdesivir for patients with COVID-19].
    Der Internist, 2020, Volume: 61, Issue:8

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient.
    Clinical chemistry and laboratory medicine, 2020, 08-27, Volume: 58, Issue:9

    Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chromatography, Liquid; Coronavirus Infections; COVID-19; Drug Monitoring; Drug Stability; Female; Furans; Humans; Limit of Detection; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyrroles; Reproducibility of Results; SARS-CoV-2; Tandem Mass Spectrometry; Triazines

2020
A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
    JAMA, 2020, 07-28, Volume: 324, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Health Care Rationing; Humans; Pandemics; Pneumonia, Viral; Resource Allocation; SARS-CoV-2; State Government

2020
Missed Opportunities on Emergency Remdesivir Use.
    JAMA, 2020, 07-28, Volume: 324, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Costs; Drugs, Investigational; Hemorrhagic Fever, Ebola; Humans; Length of Stay; National Institute of Allergy and Infectious Diseases (U.S.); Pandemics; Pneumonia, Viral; Registries; SARS-CoV-2; Treatment Outcome; United States

2020
Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease.
    The Journal of infection, 2020, Volume: 81, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Health Services Accessibility; Humans; London; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; State Medicine; United Kingdom

2020
Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir.
    JMIR public health and surveillance, 2020, 07-10, Volume: 6, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19 Drug Treatment; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Lopinavir; Randomized Controlled Trials as Topic; Research Design; Ritonavir; Treatment Outcome

2020
Optimizing Medication Management During the COVID-19 Pandemic: It Takes a Village.
    Journal of gerontological nursing, 2020, Jul-01, Volume: 46, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy; Humans; Hydroxychloroquine; Nurse-Patient Relations; Nursing Homes; Pandemics; Pneumonia, Viral; Prodrugs; SARS-CoV-2

2020
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19.
    The Journal of antimicrobial chemotherapy, 2020, 10-01, Volume: 75, Issue:10

    Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Female; Humans; Male; Pandemics; Pneumonia, Viral; Recovery of Function; SARS-CoV-2

2020
Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
    Interdisciplinary sciences, computational life sciences, 2020, Volume: 12, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Biological Products; Catalytic Domain; Computer Simulation; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Databases, Pharmaceutical; Drug Evaluation, Preclinical; Genome, Viral; Host Microbial Interactions; Humans; Ligands; Molecular Docking Simulation; Pandemics; Phylogeny; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Viral Nonstructural Proteins

2020
Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
    Obstetrics and gynecology, 2020, Volume: 136, Issue:5

    Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Interleukin-6; Lung; Oximetry; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Radiography, Thoracic; SARS-CoV-2; Treatment Outcome

2020
Case report study of the first five COVID-19 patients treated with remdesivir in France.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98

    Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; France; Hospitalization; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load; Withholding Treatment

2020
Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020, Volume: 125, Issue:5

    Topics: Adenosine Monophosphate; Adult; Alanine; Ampicillin; Angioedema; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Hyperlipidemias; Intubation, Intratracheal; Obesity; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2; Treatment Outcome

2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
    The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
    British journal of haematology, 2020, Volume: 190, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Child, Preschool; Coronavirus Infections; COVID-19; Humans; Induction Chemotherapy; Male; Pandemics; Pneumonia, Viral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; SARS-CoV-2

2020
COVID-19 Therapeutics: Making Sense of It All.
    AACN advanced critical care, 2020, 09-15, Volume: 31, Issue:3

    Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
    Antiviral research, 2020, Volume: 181

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells

2020
Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
    Annals of internal medicine, 2020, 07-21, Volume: 173, Issue:2

    Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2

2020
Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
    Journal of molecular and cellular cardiology, 2020, Volume: 146

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dexamethasone; Diabetes Mellitus; Drug Repositioning; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Obesity; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
    Cancer discovery, 2020, Volume: 10, Issue:10

    Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Betacoronavirus; Clinical Decision-Making; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drug Utilization; Follow-Up Studies; Glucocorticoids; Healthcare Disparities; Hospital Mortality; Humans; Hydroxychloroquine; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sex Factors; Treatment Outcome; United States

2020
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
    The Journal of infectious diseases, 2020, 09-01, Volume: 222, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Fever; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Time Factors; Treatment Outcome

2020
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
    Nature, 2020, Volume: 586, Issue:7827

    Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Gene Expression Regulation; Humans; Hydrazones; Induced Pluripotent Stem Cells; Models, Biological; Morpholines; Pandemics; Pneumonia, Viral; Pyrimidines; Reproducibility of Results; SARS-CoV-2; Small Molecule Libraries; Triazines; Virus Internalization; Virus Replication

2020
Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
    Journal of nanoscience and nanotechnology, 2020, 12-01, Volume: 20, Issue:12

    Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Drug Interactions; Humans; Hydrogen Bonding; Hydroxychloroquine; Ligands; Molecular Docking Simulation; Nanotechnology; Pandemics; Pneumonia, Viral; Protease Inhibitors; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Static Electricity; Viral Nonstructural Proteins

2020
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Europe; Female; Humans; Incidence; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States

2020
Liver injury in remdesivir-treated COVID-19 patients.
    Hepatology international, 2020, Volume: 14, Issue:5

    Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Italy; Liver Function Tests; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
[COVID-19: a cardiological point-of-view].
    Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:15

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Arteritis; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Venous Thrombosis

2020
Remdesivir for severe covid-19: a clinical practice guideline.
    BMJ (Clinical research ed.), 2020, 07-30, Volume: 370

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Guideline Adherence; Humans; Length of Stay; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome

2020
Communicating Science in the Time of a Pandemic.
    JAMA, 2020, 08-04, Volume: 324, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Communication; Coronavirus Infections; COVID-19; Dexamethasone; Glucocorticoids; Humans; Hydroxychloroquine; Journalism, Medical; Pandemics; Peer Review, Research; Pneumonia, Viral; SARS-CoV-2; Science

2020
Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice.
    Protein & cell, 2020, Volume: 11, Issue:10

    Topics: Adaptation, Physiological; Adenosine Monophosphate; Administration, Intranasal; Alanine; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Female; Host Specificity; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutation, Missense; Nasal Mucosa; Pandemics; Pneumonia, Viral; RNA, Viral; SARS-CoV-2; Turbinates; Vero Cells; Viral Load; Virus Replication

2020
BET 1: The role of remdesivir in COVID-19 infection.
    Emergency medicine journal : EMJ, 2020, Volume: 37, Issue:8

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Practice; Female; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
Treatments for COVID-19: where are we now?
    British journal of community nursing, 2020, 08-02, Volume: 25, Issue:8

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Immunologic Factors; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Were it business opportunities or hidden risks: Observations on clinical trials and marketing authorizations of Gilead Science's remdesivir in China.
    Die Pharmazie, 2020, 08-01, Volume: 75, Issue:8

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; China; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Industry; Drugs, Generic; Economic Competition; Humans; Pandemics; Pneumonia, Viral

2020
Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
    American journal of obstetrics and gynecology, 2020, Volume: 223, Issue:5

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome

2020
Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA, 2020, Aug-25, Volume: 324, Issue:8

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Contact Tracing; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Humans; Masks; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines

2020
Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach.
    BMC medical research methodology, 2020, 08-11, Volume: 20, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Algorithms; Antiviral Agents; Betacoronavirus; Cohort Studies; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Care; Humans; Intensive Care Units; Length of Stay; Models, Theoretical; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Survival Analysis; Survival Rate; Time Factors

2020
A Chemoenzymatic Synthesis of the (
    Biochemistry, 2020, 08-25, Volume: 59, Issue:33

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Caulobacteraceae; Coronavirus Infections; COVID-19; Humans; Molecular Structure; Pandemics; Phosphoric Triester Hydrolases; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Virus Replication

2020
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:12

    Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Betacoronavirus; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Connective Tissue Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunosuppressive Agents; Logistic Models; Lopinavir; Lupus Erythematosus, Systemic; Male; Middle Aged; Obesity; Pandemics; Pneumonia, Viral; Polymyalgia Rheumatica; Prognosis; Rheumatic Diseases; Risk Factors; Ritonavir; SARS-CoV-2; Severity of Illness Index; Sex Factors; Sjogren's Syndrome; Spondylarthropathies

2020
Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
    JAMA internal medicine, 2020, 10-01, Volume: 180, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Orphan Drug Production; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States; United States Food and Drug Administration

2020
Bilateral posterior cerebral artery territory infarction in a SARS-Cov-2 infected patient: discussion about an unusual case.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Fatal Outcome; Host-Pathogen Interactions; Humans; Infarction, Posterior Cerebral Artery; Male; Middle Aged; Pandemics; Pneumonia, Viral; Predictive Value of Tests; Risk Factors; SARS-CoV-2; Thrombolytic Therapy; Treatment Outcome

2020
Efficacy of Remdesivir in COVID-19.
    JAMA, 2020, 09-15, Volume: 324, Issue:11

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU.
    The Journal of antimicrobial chemotherapy, 2020, 11-01, Volume: 75, Issue:11

    Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Follow-Up Studies; Humans; Intensive Care Units; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome

2020
Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism.
    The American journal of bioethics : AJOB, 2020, Volume: 20, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Healthcare Disparities; Humans; Pandemics; Pneumonia, Viral; Racism; SARS-CoV-2; Social Justice; United States

2020
Antiviral treatment for COVID-19: the evidence supporting remdesivir.
    Clinical medicine (London, England), 2020, Volume: 20, Issue:6

    Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2

2020
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis.
    Therapeutic innovation & regulatory science, 2020, Volume: 54, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Clinical Trials Data Monitoring Committees; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Data Accuracy; Host Microbial Interactions; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2; Time Factors; Treatment Outcome

2020
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.
    Antimicrobial agents and chemotherapy, 2020, 10-20, Volume: 64, Issue:11

    Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; beta-Cyclodextrins; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Furans; Humans; Intensive Care Units; Lung Transplantation; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Pyrroles; Renal Dialysis; SARS-CoV-2; Transplant Recipients; Triazines

2020
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Antitubercular Agents; Antiviral Agents; Betacoronavirus; Coinfection; Comorbidity; Coronavirus Infections; COVID-19; Drug Interactions; HIV Infections; HIV-1; Humans; Mycobacterium tuberculosis; Pandemics; Pneumonia, Viral; Prevalence; Rifampin; SARS-CoV-2; Survival Analysis; Tuberculosis, Pulmonary; United States

2020
Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
    Medwave, 2020, Aug-19, Volume: 20, Issue:7

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir and COVID-19: What are the implications for Africa?
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2020, 05-07, Volume: 110, Issue:6

    Topics: Adenosine Monophosphate; Africa; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Virology, 2020, Volume: 550

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Drug Administration Schedule; Humans; Inflammation; Macaca mulatta; Models, Statistical; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load; Virus Replication

2020
Remdesivir, a remedy or a ripple in severe COVID-19?
    Expert opinion on investigational drugs, 2020, Volume: 29, Issue:11

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome

2020
Kidney Transplantation and COVID-19.
    Rhode Island medical journal (2013), 2020, 09-04, Volume: 103, Issue:8

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transplant Recipients

2020
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease.
    Blood advances, 2020, 09-22, Volume: 4, Issue:18

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Neutralizing; Antiviral Agents; Coronavirus Infections; COVID-19; Down Syndrome; Female; Heart Diseases; Humans; Immunization, Passive; Infant; Pandemics; Pneumonia, Viral; Respiratory Insufficiency

2020
COVID-19: Rescue by transcriptional inhibition.
    Science advances, 2020, Volume: 6, Issue:27

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytidine; Humans; Hydroxylamines; Pandemics; Pneumonia, Viral; Ribonucleosides; RNA-Dependent RNA Polymerase; SARS-CoV-2; Transcription, Genetic

2020
Pulmonary administration of remdesivir in the treatment of COVID-19.
    The AAPS journal, 2020, 09-17, Volume: 22, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues.
    Biomolecules, 2020, 09-21, Volume: 10, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Viral; Antigen-Antibody Reactions; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Eflornithine; Humans; Hydrophobic and Hydrophilic Interactions; Ivermectin; L-Lactate Dehydrogenase; Models, Molecular; Molecular Docking Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proline; Protein Binding; Protein Conformation; Protein Interaction Mapping; Receptors, Glycine; Saposins; SARS-CoV-2; Sofosbuvir; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship

2020
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
    International journal of biological macromolecules, 2020, Nov-15, Volume: 163

    Topics: Adenosine Monophosphate; Amino Acid Sequence; Betacoronavirus; Binding Sites; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; Enzyme Inhibitors; Folic Acid; Genome, Viral; Glucosides; Humans; Methyltransferases; Molecular Docking Simulation; Mutation; Pandemics; Pneumonia, Viral; RNA Helicases; SARS-CoV-2; Stilbenes; Vidarabine; Viral Nonstructural Proteins

2020
Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19.
    Folia medica, 2020, Sep-30, Volume: 62, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Bulgaria; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drugs, Investigational; Health Policy; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir and COVID-19.
    Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir and COVID-19.
    Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256

    Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir and COVID-19.
    Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256

    Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Remdesivir and COVID-19 - Authors' reply.
    Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Ribonucleotides; SARS-CoV-2

2020
Origins and Ownership of Remdesivir: Implications for Pricing.
    The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2020, Volume: 48, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19 Drug Treatment; Drug Discovery; Drug Repositioning; History, 21st Century; Humans; Intellectual Property; Ownership; SARS-CoV-2; United States

2020
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
    Scientific reports, 2020, 10-06, Volume: 10, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Drug Discovery; Drug Repositioning; Exonucleases; Hepacivirus; Hepatitis C; Humans; Pandemics; Pneumonia, Viral; Prodrugs; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Sofosbuvir; Viral Nonstructural Proteins; Virus Replication

2020
Audio Interview: Covid-19 and the President.
    The New England journal of medicine, 2020, 10-08, Volume: 383, Issue:15

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Federal Government; Glucocorticoids; Government Employees; HIV Protease Inhibitors; Humans; Hypoxia; Immunization, Passive; Lopinavir; Oxygen Inhalation Therapy; Pandemics; Patient Acuity; Pneumonia, Viral; Risk Assessment; SARS-CoV-2; United States; Virus Replication

2020
Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 10-27, Volume: 117, Issue:43

    Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Animals; Cells, Cultured; Chlorocebus aethiops; Coronavirus Infections; Disease Susceptibility; Gene Expression; Host Specificity; Humans; Luminescent Proteins; Mice; Vero Cells; Virus Replication

2020
Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Oct-08, Volume: 90, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Critical Care; Glucocorticoids; Hospitalization; Humans; Immunization, Passive; Midwestern United States; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers; Tertiary Healthcare

2020
Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase.
    Organic letters, 2020, 11-06, Volume: 22, Issue:21

    Topics: Adenosine Monophosphate; Alanine; Amidines; Antiviral Agents; Chemistry Techniques, Synthetic; Coronavirus Infections; COVID-19; Cyclization; Pandemics; Pneumonia, Viral

2020
Exploring RdRp-remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV.
    SAR and QSAR in environmental research, 2020, Volume: 31, Issue:11

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Molecular Docking Simulation; Pandemics; Pneumonia, Viral; Quantitative Structure-Activity Relationship; RNA-Dependent RNA Polymerase; SARS-CoV-2; Viral Proteins

2020
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies.
    Acta pharmaceutica (Zagreb, Croatia), 2021, Jun-01, Volume: 71, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Crystallography, X-Ray; Drug Discovery; Drug Repositioning; Humans; Models, Chemical; Molecular Docking Simulation; Molecular Structure; Pandemics; Pneumonia, Viral; Protease Inhibitors; Structure-Activity Relationship

2021
Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study.
    Journal of medical Internet research, 2020, 11-20, Volume: 22, Issue:11

    Topics: Adenosine Monophosphate; Alanine; Azithromycin; Chloroquine; Communication; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Federal Government; Fraud; Humans; Hydroxychloroquine; Internet; Language; Mass Media; Pandemics; Pneumonia, Viral; Public Health; United States

2020
Why do COVID death rates seem to be falling?
    Nature, 2020, Volume: 587, Issue:7833

    Topics: Adenosine Monophosphate; Age Distribution; Age Factors; Aged; Aged, 80 and over; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dexamethasone; Humans; Immunization, Passive; Intensive Care Units; Oxygen; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Time Factors; Ventilators, Mechanical

2020
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
    BMC pulmonary medicine, 2020, Nov-16, Volume: 20, Issue:1

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Humans; Hydroxychloroquine; Inflammation; Intensive Care Units; Interleukin-10; Interleukin-6; Interleukin-8; Italy; Leukocytes; Leukocytes, Mononuclear; Lopinavir; Lung; Lymphocytes; Macrophages, Alveolar; Male; Microscopy, Electron, Transmission; Middle Aged; Neutrophils; Pandemics; Pneumonia, Viral; Prognosis; Prospective Studies; Respiration, Artificial; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Survival Rate; Virion

2020
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Drug Development; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Treatment Outcome; Viral Vaccines

2020
[Nursing Experience Caring for a COVID-19 Patient With Hearing Loss].
    Hu li za zhi The journal of nursing, 2020, Volume: 67, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Communication; Coronavirus Infections; COVID-19; Hearing Loss; Humans; Male; Pandemics; Patient-Centered Care; Pneumonia, Viral; SARS-CoV-2; Social Isolation; Taiwan; Treatment Outcome

2020
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Antiviral research, 2021, Volume: 187

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Autophagy; Benzimidazoles; Bronchi; Cell Line; Coronavirus 229E, Human; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Epithelial Cells; Humans; Interferon Type I; Lung; Membrane Proteins; SARS-CoV-2; Virus Replication

2021
The race for antiviral drugs to beat COVID - and the next pandemic.
    Nature, 2021, Volume: 592, Issue:7854

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Birds; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytidine; Drug Development; Drug Industry; Europe; Humans; Hydroxylamines; Indoles; Influenza, Human; Leucine; Orthomyxoviridae; Pandemics; Pyrrolidinones; Severe Acute Respiratory Syndrome; Strategic Stockpile; United States

2021
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.
    Viruses, 2021, 04-09, Volume: 13, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Coronavirus Infections; COVID-19 Drug Treatment; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Humans; Life Cycle Stages; Middle East Respiratory Syndrome Coronavirus; SARS-CoV-2; Small Molecule Libraries

2021
Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection.
    Frontiers in cellular and infection microbiology, 2021, Volume: 11

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Ivermectin; Mice; Murine hepatitis virus; Pandemics; SARS-CoV-2

2021
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase.
    Antiviral research, 2019, Volume: 169

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus; Coronavirus Infections; Humans; Middle East Respiratory Syndrome Coronavirus; Phylogeny; RNA-Dependent RNA Polymerase; Severe acute respiratory syndrome-related coronavirus; Swine; Virus Replication

2019